New York Times: A Million Americans Need This Drug. Trump’s Deal Won’t Help Enough of Them.
A donation of H.I.V.-prevention drugs from the pharmaceutical giant Gilead could benefit shareholders more than patients.
A donation of H.I.V.-prevention drugs from the pharmaceutical giant Gilead could benefit shareholders more than patients.